| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000021216 |
| Receipt No. | R000024464 |
| Official scientific title of the study | Effect of the blue light-blocking glasses in major depressive disorder |
| Date of disclosure of the study information | 2016/02/29 |
| Last modified on | 2016/08/17 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Effect of the blue light-blocking glasses in major depressive disorder | |
| Title of the study (Brief title) | Effect of the blue light-blocking glasses in MDD | |
| Region |
|
|
| Condition | ||
| Condition | major depressive disorder | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We evaluate of efficacy and safety for blue light blocking glasses in major depressive disorder. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | VAS (visual analogue mood scales)for assessment of sleep quality
baseline and after treatment (2 weeks) |
| Key secondary outcomes | HAM-D (Hamilton Rating Scale for Depression)
BDI (Beck Depression Inventory) CGI (Clinical global impression) MEQ (morning and evening question) sleep daily baseline and after treatment (2 weeks) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Wear blue light blocking glasses from 20:00 until bedtime every evening for two weeks. | |
| Interventions/Control_2 | Wear placebo glasses (blocking only ultraviolet light) from 20:00 until bedtime every evening for two weeks. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, (DSM-V) diagnosis of major depressive disorders outpatient.
20-65 years of age, male and female. Agree to the participation in study. A score of more than 13 on the 17 item Hamilton Depressive Scale (HAM-D 17). Complain of sleep onset insomnia. |
|||
| Key exclusion criteria | Patient who has difficulty in wearing of the glasses.
Marked suicidal ideation. Patient who judged that a doctor was inappropriate. seasonal affective disorder, bipolar and psychotic disorders, substance abuse, shift work |
|||
| Target sample size | 32 | |||
| Research contact person | |
| Name of lead principal investigator | Yuichi Esaki |
| Organization | Okehazama Hospital |
| Division name | Medical office |
| Address | 3-879 sakae minamikan, toyoake, aichi |
| TEL | 0562-97-1361 |
| esakiz@fujita-hu.ac.jp | |
| Public contact | |
| Name of contact person | Yuichi Esaki |
| Organization | Okehazama Hospital |
| Division name | Medical office |
| Address | 3-879 sakae minamikan, toyoake, aichi |
| TEL | 0562-97-1361 |
| Homepage URL | |
| esakiz@fujita-hu.ac.jp | |
| Sponsor | |
| Institute | Okehazama Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Non profit organization
The Neuroscience Research Center |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024464 |